As of January 23, 2025, Accelerate Diagnostics (AXDX) has a market cap of $28.049 million USD. According to our data, Accelerate Diagnostics is ranked No.8451 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $28.05 M |
-6.67%
|
Dec 31, 2024 | $30.05 M |
-69.39%
|
Dec 29, 2023 | $98.17 M |
-44.79%
|
Dec 30, 2022 | $0.18 B |
-86.40%
|
Dec 31, 2021 | $1.31 B |
-31.13%
|
Dec 31, 2020 | $1.90 B |
-55.15%
|
Dec 31, 2019 | $4.23 B |
46.96%
|
Dec 31, 2018 | $2.88 B |
-56.11%
|
Dec 29, 2017 | $6.56 B |
26.27%
|
Dec 30, 2016 | $5.20 B |
-3.44%
|
Dec 31, 2015 | $5.38 B |
11.99%
|
Dec 31, 2014 | $4.81 B |
57.30%
|
Dec 31, 2013 | $3.06 B |
202.73%
|
Dec 31, 2012 | $1.01 B |
233.06%
|
Dec 30, 2011 | $0.30 B |
22.22%
|
Dec 31, 2010 | $0.25 B |
17.86%
|
Dec 31, 2009 | $0.21 B |
-63.48%
|
Dec 31, 2008 | $0.58 B |
-50.32%
|
Dec 31, 2007 | $1.16 B |
131.50%
|
Dec 29, 2006 | $0.50 B |
-34.21%
|
Dec 30, 2005 | $0.76 B |
44.76%
|
Dec 31, 2004 | $0.53 B |
-4.55%
|
Dec 31, 2003 | $0.55 B |
51.72%
|
Dec 31, 2002 | $0.36 B |
-31.92%
|
Dec 31, 2001 | $0.53 B |
581.60%
|
Dec 29, 2000 | $78.26 M |
-76.19%
|
Dec 31, 1999 | $0.33 B |
-74.39%
|
Dec 31, 1998 | $1.28 B |
-81.02%
|
Dec 31, 1997 | $6.76 B |
38.02%
|
Dec 31, 1996 | $4.90 B |
15,550.00%
|
Dec 29, 1995 | $31.30 M |
100.00%
|
Dec 30, 1994 | $15.65 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
QuidelOrtho
QDEL
|
$2.99 B |
-0.000 M
|
USA
|
Agilent Technologies
A
|
$43.58 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Qiagen
QGEN
|
$10.50 B |
0.000 M
|
Netherlands
|
Market Cap | = | AXDX Stock Price | * | AXDX Shares Outstanding |
= | $1.12 | * | 25.04 M | |
= | $28.05 M |